We are happy to announce the IP protection in Mexico for all Pediococcus acidilactici strains, including the P. acidilactici KABPTM 053 (CECT 8633).
This new patent covers the use of a P. acidilactici strain for treatment of any disorder in combination with at least one antiseptic.
P.acidilactici KABP TM 053 (CECT 8633) is included in the 3-strain probiotic formula AB-DENTALAC, which have clinically demonstrated positive effects in patients oral health.
From now on, AB-BIOTICS products sold in Mexico including P. acidilactici will be able to indicate in their labels the identification code “Mexican Patent MX 379324” .
AB-BIOTICS keeps putting all the efforts in the microbiome research beyond the gut, covering a wide range of therapeutic areas where microbiota has demonstrated to play a critical role in health and disease.
Authors: Mercè Mengual (Pharmacist)
AB-BIOTICS SA
Av. Torre Blanca 57
ESADE Creapolis Building
Sant Cugat del Valles
08172 Spain
(+34) 935 803 876
Kaneka Americas Holding, Inc.
Probiotics Division
7979 Gateway Boulevard
Newark (California)
94560 United States
AB-BIOTICS Pte Ltd
10 Anson Road #12-14
International Plaza
Singapore 079903